4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-16-012181
CIK 0001316175operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 7:33 PM ET
Size
5.4 KB
Accession
0001214659-16-012181
Insider Transaction Report
Form 4
Dickinson Klara
SVP & Chief Regulatory Officer
Transactions
- Award
Stock option (right to buy)
2016-06-09+105,000→ 105,000 totalExercise: $3.52Exp: 2026-06-09→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]This stock option vests monthly over four years beginning January 1, 2016 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start date and will expire on June 9, 2026.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 7:33 PM ET
- Size
- 5.4 KB